| Brand Name | Cure Meds |
|---|---|
| Industry / Business Category | Pharmacies / Healthcare Retail |
| Founded Year | 2023 |
| Franchise Started Year | 2023 |
| Total Franchise Outlets | 1–10 |
| Estimated Investment | INR 30 Lakh – 50 Lakh |
| Franchise Fee | INR 4,00,000 |
| Royalty Fee | 5% |
| Space Requirement | 200–500 sq.ft |
| Staff Requirement | Pharmacy staff, administrative support |
| Expected Payback Period | 2–3 years |
Cure Meds is an Indian pharmacy franchise operating within the healthcare retail sector. The brand provides franchise partners with access to pharmaceutical products, prescription medications, and wellness items. Its services target communities seeking reliable access to healthcare products, and franchisees looking to operate a medical store under a recognized brand.
Cure Meds operates as a pharmacy retail network. Customers visit franchise outlets to purchase prescription medicines, over-the-counter products, and wellness items. Franchise outlets generate revenue through direct product sales. Daily operations include inventory management, product stocking, customer service, and adherence to pharmaceutical regulations.
| Pharmaceutical Products | Prescription and over-the-counter medications |
|---|---|
| Wellness Solutions | Vitamins, supplements, and personal care products |
| Healthcare Support | Customer guidance on product use and wellness recommendations |
| Franchise Partner Role | Owns and operates a Cure Meds pharmacy outlet |
|---|---|
| Responsibilities of Franchise Owner | Manage inventory, customer service, regulatory compliance, and day-to-day store operations |
| Outlet Operation | Retail pharmacy serving local communities with medicine and wellness products |
| Franchisor Support | Cure Meds provides training, marketing materials, supply chain management, and operational guidance |
| Estimated Investment | INR 30 Lakh – 50 Lakh, covering store setup, initial inventory, and branding |
|---|---|
| Franchise Fee | INR 4,00,000 |
| Setup Costs | Interior design, shelving, computers, and initial stock |
| Royalty / Ongoing Fees | 5% of revenue |
| Space Requirement | 200–500 sq.ft for retail operations |
|---|---|
| Preferred Locations | Urban and semi-urban areas with customer footfall |
| Equipment / Infrastructure Needs | Shelving, display units, refrigeration (if required), billing systems, and storage |
| Staffing Requirements | Pharmacists, assistants, and administrative personnel |
| Revenue Sources | Sale of prescription medicines, OTC products, and wellness items |
|---|---|
| Customer Demand | Driven by local community needs, prescriptions, and wellness trends |
| Repeat Purchase Potential | High, due to recurring prescriptions and continuous demand for health products |
| Operational Cost Considerations | Inventory procurement, staffing, and basic utilities |
| Expected Payback Period | 2–3 years |
| Established Year | 2023 |
|---|---|
| Franchise Commencement | 2023 |
| Current Network | 1–10 outlets initially |
| Geographic Markets Served | Urban and semi-urban Indian markets |
| Expansion Plans | Scaling the franchise network across additional regions in India |
Cure Meds provides a structured pharmacy franchise model with access to pharmaceutical and wellness products, operational support, and a scalable retail framework suitable for investors entering the healthcare sector.
A: The investment ranges from INR 30 Lakh to 50 Lakh, including store setup, initial inventory, and franchise fee.
A: Franchisees operate a pharmacy outlet selling prescription medications, OTC products, and wellness items, supported by training and supply chain management from the brand.
A: Franchise operations require 200–500 sq.ft of retail and storage space.
A: Payback is typically expected within 2–3 years, depending on sales performance and location.
A: Prospective franchisees can contact Cure Meds directly to discuss available territories, review terms, and complete the franchise agreement. ## Similar Franchise Opportunities
Disclaimer: All scores, rankings, and estimates on ForeFind are independently produced editorial assessments using publicly available data and validated brand-submitted information. They are not verified facts, financial advice, or investment recommendations. Full Disclaimer.